Caxton Associates LP Bio Rad Laboratories, Inc. Transaction History

Caxton Associates LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$268.26 - $339.48 $1.02 Million - $1.28 Million	3,785 New	3,785 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $2.37 Million - $3.22 Million	8,813 Added 472.8%	10,677 $3.45 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $652,866 - $787,782	1,864 New	1,864 $668,000
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $704,475 - $913,388	2,003 Added 244.57%	2,822 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $201,343 - $274,870	-488 Reduced 37.34%	819 $342,000
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $349,607 - $450,258	754 Added 136.35%	1,307 $647,000
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $67,669 - $94,869	-129 Reduced 18.91%	553 $311,000
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $483,428 - $541,971	682 New	682 $515,000
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $811,614 - $1.02 Million	-1,234 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $145,889 - $164,207	253 Added 25.79%	1,234 $795,000
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $536,616 - $649,765	981 New	981 $560,000
Q3 2017 Nov 14, 2017	SELL	$212.27 - $242.28 $616,219 - $703,338	-2,903 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	2,903	2,903 $657,000

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.42B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.